Page 10 - Pharma

Pharma margins to get rupee boost in Q2, highlights report

This would also safeguard them from margin pressure, said the report

Relax environment norms for export growth, say pharmaceutical firms

Under the current norms, pollution control boards lay down permissible effluent limits while granting approval

Pharma majors plan $2-billion investments to tap new business

India's drug makers spent $1.4 billion in the previous financial on R&D

Pharma industry grows 29% to Rs 2.04 lakh cr in 2015-16

The sector saw FDI equity inflows of $2.25 bn from Apr 2014-Mar 2016, says report

We need a common regulator for pharma sector: Ficci chairman

Pankaj Patel said this would simplify the processes and improve ease of doing business

Indian exports to be hit? Prioritising job creation, Trump targets pharmas

President-elect Donald Trump has announced that creating jobs would be the cornerstone of his presidency and took aim at the pharmaceutical sector vowing to bring the industry back to the US.

Pharma exports from Gujarat grow six-fold in last decade

Gujarat houses nearly 135 licensed medical devices manufacturers in the country

Pharma shares in focus; Lupin, Sun Pharma, Aurobindo up over 3%

The S&P BSE Healthcare index was up 2.4% as compared to 1.5% rise in the S&P BSE Sensex at 02:55 pm

Pharma shares under pressure; Nifty Pharma index down over 3%

Dr Reddys, Sun Pharma, Lupin, Glenmark Pharma and Cadila Healthcare were down between 4% and 5% on the NSE.

Pharma shares surge post Q2 results

Strides Shasun, Jubilant Life Sciences and Sun Pharma Advanced Research were up between 5% and 12%.

SC setback for pharma majors

Total amount these firms owe to government is around Rs 3,500 crore

Three pharma companies to focus on

Aurobindo, Glenmark, Natco see strong domestic and US growth, which should reflect in results

Drug makers go the digital way, arm medical representatives with apps and tablets

Digital platforms are making it simpler for the drug companies to communicate with doctors

PI Industries plans foray into pharma sector

Company has made an investment to the tune of Rs 321.44 crore in FY16 to set up two new state-of-the-art manufacturing facilities

Pharma firms get time to adopt uniform marketing code

The idea behind a uniform code is to ensure fair marketing in the sector. Medical device makers, too, will have to comply

Pharma shares in focus; Divis Lab, Ajanta, Natco, Torrent Pharma hit record highs

Sequent Scientific, Torrent Pharma, Hikal, Ipca Lab and Aurobindo Pharma were up between 5%-20% on the BSE.

Gujarat gears up to woo fresh pharma investments as tax havens lose relevance

Already several mid-sized cos have started scouting land; state govt setting up pharma and medical devices park; bets on existing eco-system

What is ailing the pharma sector?

Low growth visibility and trouble with regulators have resulted in lack of interest from investors

Govt mulling making pharma mkting uniform code compulsory

Savings to consumers on account of revision and price fixing of essential drugs amounted to Rs 4,988 crore in the last two years

Pharma sector receives Rs 4,975-cr FDI in FY16: Govt

FDI policy provides for 100 per cent FDI under automatic route in greenfield pharma